Percutaneous Venous Introducer 10264
510(k) K965167
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK965167 | Date25 Jul 1997 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DYB
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1340
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 22 Sep 2026
The Percutaneous Venous Introducer 10264 is a medical device designed to provide access to the venous system for the insertion of catheters, ports, and pacing leads. It is intended to create a percutaneous pathway for the introduction of these devices into the venous vasculature.
Manufactured by Medamicus, Inc., the device was cleared through the FDA 510(k) pathway on July 25, 1997, under K965167 and is classified as a Class 2 device under product code DYB. It is supplied as a single-use device for use in clinical settings where venous access is required.
Other devices from Medamicus, Inc.
Questions
AI-generated answers, 22 Sep 2026
What is the Percutaneous Venous Introducer 10264 used for?
The Percutaneous Venous Introducer 10264 is designed to create a percutaneous pathway into the venous system to allow insertion of catheters, ports, and pacing leads. It facilitates venous access for these devices in clinical settings.
Is the Percutaneous Venous Introducer 10264 reusable or single-use?
The Percutaneous Venous Introducer 10264 is supplied as a single-use device, meaning it is intended for one patient and one procedure only, then discarded to prevent cross-contamination and ensure sterility.
How was the Percutaneous Venous Introducer 10264 cleared for market?
The Percutaneous Venous Introducer 10264 received market clearance through the FDA 510(k) pathway on July 25, 1997, under submission K965167, demonstrating substantial equivalence to a predicate device.